市場調查報告書

細胞化驗的全球市場:各產品、技術、應用、終端用戶、地區成長率,趨勢及預測(2018年∼2023年)

Global Cell-Based Assay Market - Segmented by Product, Technology, Application, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023)

出版商 Mordor Intelligence LLP 商品編碼 390837
出版日期 內容資訊 英文 112 Pages
商品交期: 2-3個工作天內
價格
Back to Top
細胞化驗的全球市場:各產品、技術、應用、終端用戶、地區成長率,趨勢及預測(2018年∼2023年) Global Cell-Based Assay Market - Segmented by Product, Technology, Application, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023)
出版日期: 2018年05月01日內容資訊: 英文 112 Pages
簡介

全球細胞化驗市場,預計從2018年到2023年的預測期間內以8.2%的年複合成長率成長。細胞化驗,是醫療保健中多種目的的研究實驗室工具,為了決定藥物的功能性及有效性,使用抗體或其他部分以特定的細胞為標的進行設計。 R&D的支出增加,政府所實行的措施的強化,技術創新的發展等,成為北美支配該市場的幫助。

本報告提供全球細胞化驗市場調查,整體市場趨勢,各產品、技術、應用、終端用戶、地區的詳細趨勢,市場成長的影響要素分析,競爭情形,主要企業簡介等資訊總括性彙整。

目錄

第1章 簡介

  • 市場定義

第2章 調查方法

第3章 摘要整理

第4章 主要影響要素

第5章 市場概要

  • 目前市場方案
  • 波特的五力分析
    • 供應商談判力
    • 消費者談判力
    • 新加入廠商的威脅
    • 替代產品及服務的威脅
    • 產業內的競爭

第6章 成長要素,阻礙因素,機會,課題分析(DROC)

  • 成長要素
    • 慢性疾病及文明病的流行
    • 發現新藥的研究開發的投資增加
    • 細胞基礎的方法論的技術進步的高漲
    • 高通量篩檢法的採用的增加
  • 阻礙因素
    • 高維修運用與成本
    • 運用這些技術的熟練者不足
    • 嚴密的控制途徑
  • 市場機會
  • 主要課題

第7章 市場區隔

  • 各產品
    • 細胞株
    • 試劑及套件
    • 金屬板
    • 其他的消耗品
  • 各技術
    • 自動處理
    • 流式細胞技術
    • 免標定檢測
    • 高通量篩檢
    • 其他
  • 各應用領域
    • 藥物研發
    • ADME研究
    • 其他應用
  • 終端用戶
    • 學術機構
    • 製藥及生物科技企業
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第8章 競爭情形

  • M&A分析
  • 協定,合作,夥伴關係
  • 新產品的銷售

第9章 主要企業

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Corning, Inc.
  • Danaher Corporation
  • DiscoverX Corporation
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • Perkin Elmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.
  • 其他

第10章 市場未來展望

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 52690

The global cell-based assay market is expected to register a CAGR of 8.2% during the forecast period of 2018-2023. Cell-based assays are versatile research lab tool in healthcare, designed to target specific cells using antibodies or other moieties, to determine the functionality and efficacy of drugs. The higher expenditure on R&D, favorable government initiatives, and more technological advancements help North America to dominate this market.

Rising Chronic Diseases and Lifestyle Disorders

The rising prevalence of chronic diseases and lifestyle disorders, such as cancer, arthritis, cardiovascular, diabetes, and epilepsy, is one of the primary factors for the growth of this market. The cell-based assays for nervous system and chronic pain drug discovery provide new opportunities in the search for novel medicines for neurodegenerative diseases and pain. Cell-based assays are highly useful in screening mutagenesis in case of various types of cancers, such as chronic myeloid leukemia. According to the Center for Disease Control and Prevention, seven of the top 10 diseases in 2014 were chronic diseases. Thus, the rise in chronic diseases provides rising demand for cell-based assays for newer drug discoveries, making it a vital factor for the growth of this market.

Other factors playing a vital role for the growth of this market include increasing investments in R&D for drug discovery, technological advancements in cell-based methodologies, and rising adoption of high-throughput screening methods, particularly in toxicological studies.

High Maintenance and Operational Costs

One of the major factors restraining the cell-based assays market is the high maintenance of instruments and their operational costs. With the involvement of significant cost in operations, the market becomes less attractive in large-scale applications. For example, high cost associated with the CellKey system and RT-CES. With that, there is an increased cost for coated plates, which are not readily affordable. This forces several companies and research labs to find cost-effective alternatives, such as pre-treating of plates with collagen, thereby, impeding the growth of the market.

Along with this, other factors such as lack of skilled professionals and stringent regulatory pathways linked to instruments, reagents, and kits hamper the growth of this market.

United States to Hold the Largest Market Share

The United States is expected to have the largest market share in the forecast period. The dominance is primarily attributed to the rising availability of funds for research and extensive drug discovery activities in the country from multinational firms in collaborations with domestic companies and research institutes. The Asia-Pacific region also posses a potential market for the growth of cell-based assays due to a large patient pool, rising economies, and rising assays applications, with China and India being profitable markets.

Key Developments in the Market

February 2018: Imec, one of the leaders in nanoelectronics and digital technologies, designed and fabricated a 16,384-electrode, 1,024-channel micro-electrode array for high-throughput multi-modal cell interfacing.

January 2018: Agilent Technologies expanded its cell analysis portfolio by the acquisition of Luxcel Biosciences, involved in the development of real-time fluorescence plate-reader based on in-vitro cell assay kits.

Major players: BECTON, DICKINSON AND COMPANY, BIO-RAD LABORATORIES, INC., CORNING, INC., DANAHER CORPORATION, DISCOVERX CORPORATION, F. HOFFMANN-LA ROCHE LTD, MERCK KGAA, PERKIN ELMER, INC., PROMEGA CORPORATION, AND THERMO FISHER SCIENTIFIC, INC., amongst others.

Reasons to Purchase the Report

A look at the current and future of the global cell-based assays market in the developed and emerging regions.

Analyzing various perspectives of the market with the help of Porter's Five Forces Analysis.

Identify the segment that is expected to dominate the market.

Identify the regions that are expected to witness the fastest growth during the forecast period.

Identify the latest developments, market shares, and strategies employed by the major market players.

3 months analyst support along with the Market Estimate sheet (in Excel).

Customization of the Report

This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.

Table of Contents

1. Introduction

  • 1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

  • 5.1 Current Market Scenario
  • 5.2 Porter's Five Forces Analysis
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Consumers
    • 5.2.3 Threat of New Entrants
    • 5.2.4 Threat of Substitute Products and Services
    • 5.2.5 Competitive Rivalry within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

  • 6.1 Drivers
    • 6.1.1 Rising Prevalence of Chronic Diseases and Lifestyle Disorders
    • 6.1.2 Increasing Investments in Research and Development for Drug Discovery
    • 6.1.3 Rise in Technological Advancements in Cell-based Methodologies
    • 6.1.4 Rising Adoption of High-Throughput Screening Methods
  • 6.2 Restraints
    • 6.2.1 High Maintenance and Operational Costs
    • 6.2.2 Lack of Skilled Personnels to Operate these Technologies
    • 6.2.3 Stringent Regulatory Pathways
  • 6.3 Opportunities
  • 6.4 Key Challenges

7. Market Segmentation

  • 7.1 By Product
    • 7.1.1 Cell Lines
      • 7.1.1.1 Primary Cell Lines
      • 7.1.1.2 Stem Cell Lines
      • 7.1.1.3 Others
    • 7.1.2 Reagents and Kits
    • 7.1.3 Mircoplates
    • 7.1.4 Other Consumables
  • 7.2 By Technology
    • 7.2.1 Automated Handling
    • 7.2.2 Flow Cytometry
    • 7.2.3 Label-Free Detection
    • 7.2.4 High-Throughput Screening
    • 7.2.5 Others
  • 7.3 By Application
    • 7.3.1 Drug Discovery
    • 7.3.2 ADME Studies
    • 7.3.3 Other Applications
  • 7.4 By End User
    • 7.4.1 Academia
    • 7.4.2 Pharmaceutical and Biotechnology Companies
    • 7.4.3 Others
  • 7.5 By Geography
    • 7.5.1 North America
      • 7.5.1.1 United States
      • 7.5.1.2 Canada
      • 7.5.1.3 Mexico
      • 7.5.1.4 Rest of North America
    • 7.5.2 Europe
      • 7.5.2.1 France
      • 7.5.2.2 Germany
      • 7.5.2.3 United Kingdom
      • 7.5.2.4 Italy
      • 7.5.2.5 Spain
      • 7.5.2.6 Rest of Europe
    • 7.5.3 Asia-Pacific
      • 7.5.3.1 China
      • 7.5.3.2 Japan
      • 7.5.3.3 India
      • 7.5.3.4 Australia
      • 7.5.3.5 South Korea
      • 7.5.3.6 Rest of Asia-Pacific
    • 7.5.4 Middle East & Africa
      • 7.5.4.1 GCC
      • 7.5.4.2 South Africa
      • 7.5.4.3 Rest of the Middle East & Africa
    • 7.5.5 South America
      • 7.5.5.1 Brazil
      • 7.5.5.2 Argentina
      • 7.5.5.3 Rest of South America

8. Competitive Landscape

  • 8.1 Mergers & Acquisition Analysis
  • 8.2 Agreements, Collaborations, and Partnerships
  • 8.3 New Products Launches

9. Key Players

  • 9.1 Becton, Dickinson and Company
  • 9.2 Bio-Rad Laboratories, Inc.
  • 9.3 Corning, Inc.
  • 9.4 Danaher Corporation
  • 9.5 DiscoverX Corporation
  • 9.6 F. Hoffmann-La Roche Ltd
  • 9.7 Merck KGaA
  • 9.8 Perkin Elmer, Inc.
  • 9.9 Promega Corporation
  • 9.10 Thermo Fisher Scientific, Inc.
  • 9.11 List not Exhaustive

10. Future of the Market

Back to Top